A semen panel signature comprising sTWEAK Cytokine levels and expression of exomiR-221-3p and exomiR-222-3p for assessing prostate cancer prognosis, diagnostic utility, and detection of upgrading during active surveillance
{{output}}
Purpose: To evaluate the seminal biomarker signature (sTWEAK, exomiR-221-3p, and exomiR-222-3p) in several prostate cancer (PCa) settings: diagnosis, tumour aggressiveness prognosis [ISUP grade in radical prostatectomy (RP) speci... ...
